IRF5 and rheumatoid arthritis: Recently, Bo et al. analyzed the serum of rheumatoid arthritis patients and suggests exposure to MAP can trigger specific humoral immune response against host IRF5 protein due to molecular mimicry between MAP_402718−32 and IRF5424-434 peptides in rheumatoid arthritis patients [77].